Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., Sever, P. S., & Pedersen, T. R. (2017). Evolocumab and clinical outcomes in patients with cardiovascular disease. New England Journal of Medicine, 376(18), 1713–1722. https://doi.org/10.1056/nejmoa1615664
(Sabatine et al., 2017)Sabatine et al. (2017)@article{sabatine2017evolocumab,
title = {Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease},
author = {Sabatine, Marc S. and Giugliano, Robert P. and Keech, Anthony C. and Honarpour, Narimon and Wiviott, Stephen D. and Murphy, Sabina A. and Kuder, Julia F. and Wang, Huei and Liu, Thomas and Wasserman, Scott M. and Sever, Peter S. and Pedersen, Terje R.},
journal = {New England Journal of Medicine},
year = {2017},
volume = {376},
number = {18},
pages = {1713--1722},
publisher = {Massachusetts Medical Society},
doi = {10.1056/nejmoa1615664}
}